---
schema_version: "secwatch.filing_event.v1"
accession: "0001753926-25-001425"
form_type: "8-K"
ticker: "PTHS"
cik: "0001919246"
company_name: "Pelthos Therapeutics Inc."
filed_at: "2025-09-03T23:59:59+00:00"
generated_at: "2026-05-17T08:39:19.458475+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "low"
source: SEC EDGAR
---

# Pelthos Therapeutics to present at Wells Fargo 2025 Healthcare Conference on Sept 3

## Summary
- CEO Scott Plesha and CFO Frank Knuettel to present at Wells Fargo Healthcare Conference on Sept 3, 2025 at 1:30 pm ET.
- Company to provide pipeline update and discuss commercial launch of ZELSUVMI (berdazimer) for molluscum contagiosum.
- Webcast and replay available on company's website for 90 days.

## SEC filing metadata
- accession: 0001753926-25-001425
- form_type: 8-K
- ticker: PTHS
- cik: 0001919246
- company_name: Pelthos Therapeutics Inc.
- filed_at: 2025-09-03T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1919246/000175392625001425/0001753926-25-001425-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1919246/000175392625001425/g084940_8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001753926-25-001425
- JSON: https://secwatch.observer/filing/0001753926-25-001425.json
- Plain text: https://secwatch.observer/filing/0001753926-25-001425.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.